IQVIA HOLDINGS INC
IQVNYSE🏆 #324 by market capEarnings Oct 26 · PreUS Equity
$269.28▼ $1.67 (−0.62%)
LiveTrack IQV
Get earnings, price moves & breaking news on Telegram
24h▼ 0.6%
7d▼ 0.3%
14d▼ 0.1%
30d▲ 3.0%
ytd▲ 19.4%
1y▲ 48.8%
🏦Market Cap
$44.32B
Mid Cap
📈Revenue Growth (YoY)
+5.9%
Slowing
📊Gross Margin
26.2%
Moderate
💵FCF Margin
15.4%
Healthy
⚖️P/S Ratio
2.6x
Cheap
Otter Score
84
Good
IQVIA HOLDINGS INC
IQVAnalyst Ratings
Price
$269.28
Total
45
Raised
9
Lowered
2
Avg PT
$255.33
H / L
$329 / $185
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Truist Securities | Reiterated | Buy | 2026-09-28 | — | — |
Morgan Stanley | Reiterated | Equal Weight | 2026-09-17 | $270.00 | +0.30% |
Baird | Reiterated | Outperform | 2026-07-29 | — | — |
RBC Capital | Reiterated | Outperform | 2026-07-29 | $247.00 | −8.30% |
BMO Capital | Reiterated | Outperform | 2026-07-29 | $270.00 | +0.30% |
JP Morgan | Reiterated | Overweight | 2026-07-29 | — | — |
Stifel | Reiterated | Buy | 2026-07-29 | — | — |
TD Cowen | Reiterated | Buy | 2026-07-29 | — | — |
Mizuho | Reiterated | Outperform | 2026-07-13 | — | — |
Evercore ISI Group | Reiterated | Outperform | 2026-04-08 | — | — |
Barclays | Upgraded | Equal Weight → Overweight | 2026-03-06 | $210.00 | −22.00% |
Citigroup | Reiterated | Neutral | 2026-02-06 | $320.00 | +18.80% |
UBS | Reiterated | Buy | 2026-02-06 | $240.00 | −10.90% |
Jefferies | Reiterated | Buy | 2026-02-06 | — | — |
HSBC | Upgraded | Hold → Buy | 2025-10-09 | $240.00 | −10.90% |
B of A Securities | Reiterated | Buy | 2024-12-13 | — | — |
Leerink Partners | Reiterated | Outperform | 2024-11-19 | — | — |
Goldman Sachs | Reiterated | Buy | 2024-11-01 | $270.00 | +0.30% |
Deutsche Bank | Reiterated | Buy | 2024-11-01 | $240.00 | −10.90% |
BTIG | Reiterated | Buy | 2024-11-01 | — | — |
Guggenheim | Downgraded | Buy → Neutral | 2024-02-15 | $267.00 | −0.80% |
Wells Fargo | Reiterated | Equal Weight | 2023-05-01 | $235.00 | −12.70% |
Credit Suisse | Reiterated | Outperform | 2023-02-13 | $272.00 | +1.00% |
Cowen & Co. | Reiterated | Outperform | 2022-12-06 | $275.00 | +2.10% |
SVB Leerink | Reiterated | Outperform | 2022-07-15 | — | — |
Piper Sandler | Upgraded | Neutral → Overweight | 2022-04-29 | $255.00 | −5.30% |
Keybanc | Reiterated | Overweight | 2022-04-28 | $290.00 | +7.70% |
Argus Research | Reiterated | Buy | 2021-09-10 | $290.00 | +7.70% |
Stephens & Co. | Upgraded | Equal Weight → Overweight | 2021-04-16 | — | — |
KeyBanc | Upgraded | Sector Weight → Overweight | 2021-03-08 | $290.00 | +7.70% |
SunTrust Robinson Humphrey | Reiterated | Buy | 2020-04-29 | — | — |
CFRA | Reiterated | Buy | 2020-03-24 | — | — |
Stifel Nicolaus | Reiterated | Buy | 2020-02-13 | $220.00 | −18.30% |
Wolfe Research | Upgraded | Peer Perform → Outperform | 2019-11-14 | — | — |
Argus | Reiterated | Buy | 2019-02-25 | — | — |
Raymond James | Reiterated | Strong Buy | 2018-08-31 | — | — |
Bank of America | Upgraded | Neutral → Buy | 2018-07-25 | — | — |
Mitsubishi UFJ | Reiterated | Neutral | 2017-12-15 | — | — |
William Blair | Upgraded | Market Perform → Outperform | 2017-08-04 | — | — |
PiperJaffray | Downgraded | Overweight → Neutral | 2016-10-27 | — | — |
Pacific Crest | Reiterated | Overweight | 2016-07-28 | — | — |
Avondale Partners | Reiterated | Market Perform | 2016-05-03 | — | — |
Wunderlich | Reiterated | Buy | 2014-11-26 | — | — |
ISI Group | Upgraded | Neutral → Buy | 2014-10-10 | — | — |
Sterne Agee | Reiterated | Underperform | 2013-06-11 | — | — |
Institution
Truist Securities
Reiterated · Buy · 2026-09-28
—
—
Morgan Stanley
Reiterated · Equal Weight · 2026-09-17
$270.00
+0.30%
Baird
Reiterated · Outperform · 2026-07-29
—
—
RBC Capital
Reiterated · Outperform · 2026-07-29
$247.00
−8.30%
BMO Capital
Reiterated · Outperform · 2026-07-29
$270.00
+0.30%
JP Morgan
Reiterated · Overweight · 2026-07-29
—
—
Stifel
Reiterated · Buy · 2026-07-29
—
—
TD Cowen
Reiterated · Buy · 2026-07-29
—
—
Mizuho
Reiterated · Outperform · 2026-07-13
—
—
Evercore ISI Group
Reiterated · Outperform · 2026-04-08
—
—
Barclays
Upgraded · Equal Weight → Overweight · 2026-03-06
$210.00
−22.00%
Citigroup
Reiterated · Neutral · 2026-02-06
$320.00
+18.80%
UBS
Reiterated · Buy · 2026-02-06
$240.00
−10.90%
Jefferies
Reiterated · Buy · 2026-02-06
—
—
HSBC
Upgraded · Hold → Buy · 2025-10-09
$240.00
−10.90%
B of A Securities
Reiterated · Buy · 2024-12-13
—
—
Leerink Partners
Reiterated · Outperform · 2024-11-19
—
—
Goldman Sachs
Reiterated · Buy · 2024-11-01
$270.00
+0.30%
Deutsche Bank
Reiterated · Buy · 2024-11-01
$240.00
−10.90%
BTIG
Reiterated · Buy · 2024-11-01
—
—
Guggenheim
Downgraded · Buy → Neutral · 2024-02-15
$267.00
−0.80%
Wells Fargo
Reiterated · Equal Weight · 2023-05-01
$235.00
−12.70%
Credit Suisse
Reiterated · Outperform · 2023-02-13
$272.00
+1.00%
Cowen & Co.
Reiterated · Outperform · 2022-12-06
$275.00
+2.10%
SVB Leerink
Reiterated · Outperform · 2022-07-15
—
—
Piper Sandler
Upgraded · Neutral → Overweight · 2022-04-29
$255.00
−5.30%
Keybanc
Reiterated · Overweight · 2022-04-28
$290.00
+7.70%
Argus Research
Reiterated · Buy · 2021-09-10
$290.00
+7.70%
Stephens & Co.
Upgraded · Equal Weight → Overweight · 2021-04-16
—
—
KeyBanc
Upgraded · Sector Weight → Overweight · 2021-03-08
$290.00
+7.70%
SunTrust Robinson Humphrey
Reiterated · Buy · 2020-04-29
—
—
CFRA
Reiterated · Buy · 2020-03-24
—
—
Stifel Nicolaus
Reiterated · Buy · 2020-02-13
$220.00
−18.30%
Wolfe Research
Upgraded · Peer Perform → Outperform · 2019-11-14
—
—
Argus
Reiterated · Buy · 2019-02-25
—
—
Raymond James
Reiterated · Strong Buy · 2018-08-31
—
—
Bank of America
Upgraded · Neutral → Buy · 2018-07-25
—
—
Mitsubishi UFJ
Reiterated · Neutral · 2017-12-15
—
—
William Blair
Upgraded · Market Perform → Outperform · 2017-08-04
—
—
PiperJaffray
Downgraded · Overweight → Neutral · 2016-10-27
—
—
Pacific Crest
Reiterated · Overweight · 2016-07-28
—
—
Avondale Partners
Reiterated · Market Perform · 2016-05-03
—
—
Wunderlich
Reiterated · Buy · 2014-11-26
—
—
ISI Group
Upgraded · Neutral → Buy · 2014-10-10
—
—
Sterne Agee
Reiterated · Underperform · 2013-06-11
—
—
One row per institution · price target from the firm's latest published target